Oaktree Acquisition Corp. III Life Sciences (OACC) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | - | - | - | - | - |
| Revenue Growth % | - | - | - | - | - |
| Cost of Goods Sold | - | - | - | - | - |
| COGS % of Revenue | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - |
| Operating Expenses | 456.54K | 225.58K | 269.81K | 303.71K | 48.09K |
| OpEx % of Revenue | - | - | - | - | - |
| Selling, General & Admin | 456.54K | 225.58K | 269.81K | 303.71K | 48.09K |
| SG&A % of Revenue | - | - | - | - | - |
| Research & Development | - | - | - | - | - |
| R&D % of Revenue | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - |
| Operating Income | -456.54K | -225.58K | -269.81K | -303.71K | -48.09K |
| Operating Margin % | - | - | - | - | - |
| Operating Income Growth % | - | -369.03% | - | - | - |
| EBITDA | -456.54K | -225.58K | -269.81K | -303.71K | -48.09K |
| EBITDA Margin % | - | - | - | - | - |
| EBITDA Growth % | - | -369.03% | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 |
| EBIT | -456.54K | -225.58K | -269.81K | -303.71K | -48.09K |
| Net Interest Income | 1.85M | 2.19M | 2.14M | 1.59M | 0 |
| Interest Income | 1.85M | 2.19M | 2.14M | 1.59M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | - | - | - | - | - |
| Pretax Income | 1.39M | 1.97M | 1.87M | 1.38M | -48.09K |
| Pretax Margin % | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% |
| Net Income | 1.39M | 1.97M | 1.87M | 1.38M | -48.09K |
| Net Margin % | - | - | - | - | - |
| Net Income Growth % | - | 4189.29% | - | - | - |
| Net Income (Continuing) | 1.39M | 1.97M | 1.87M | 1.38M | -48.09K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.06 | 0.08 | 0.08 | 0.06 | -0.00 |
| EPS Growth % | - | - | - | - | - |
| EPS (Basic) | 0.06 | 0.08 | 0.08 | 0.06 | -0.00 |
| Diluted Shares Outstanding | 19.2M | 19.2M | 24.58M | 24.58M | 22.43M |
| Basic Shares Outstanding | 19.2M | 19.2M | 24.58M | 24.58M | 22.43M |
| Dividend Payout Ratio | - | - | 226.63% | - | - |